Felzartamab Uses, Dosage, Side Effects and more
Felzartamab is under investigation in clinical trial NCT04145440 (Trial to Assess Safety and Efficacy of MOR202 in Anti-pla2r + Membranous Nephropathy (Amn)).
| Trade Name | Felzartamab |
| Generic | Felzartamab |
| Felzartamab Other Names | Felzartamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
